BPC-157
Pentadecapeptide with extensive animal/in vitro literature (injury and GI models). Robust human efficacy evidence is lacking.
Stacks containing BPC-157
Public community stacks that include this ingredient.
Groups gut-inflammation oriented peptides (mostly studied in preclinical colitis/inflammation models).
Adds a copper peptide often discussed in cosmetic/skin contexts to a recovery/joint pairing. Evidence is indirect and component-based.
Groups the two most commonly paired research peptides discussed in injury-repair circles; evidence is largely preclinical and not athlete-RCT grade.
A phase 1 safety/PK study in healthy volunteers was registered; results were not posted and the submission was canceled per later reviews, limiting interpretability.
Across animal models, BPC-157 is frequently reported to improve healing-related outcomes (tendon/ligament/muscle/bone and GI injury models), but translation to humans remains unproven.
Multiple preclinical models report improvements in healing-related endpoints; translation to humans remains unproven.